56
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia

, , , &
Pages 279-290 | Published online: 07 May 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Panagiota Papanagnou, Theodora Stivarou, Ioannis Papageorgiou, Georgios E Papadopoulos & Anastasios Pappas. (2017) Marketed drugs used for the management of hypercholesterolemia as anticancer armament. OncoTargets and Therapy 10, pages 4393-4411.
Read now

Articles from other publishers (7)

Samanta Mecocci, Federica Gevi, Daniele Pietrucci, Luca Cavinato, Francesco R. Luly, Luisa Pascucci, Stefano Petrini, Fiorentina Ascenzioni, Lello Zolla, Giovanni Chillemi & Katia Cappelli. (2020) Anti-Inflammatory Potential of Cow, Donkey and Goat Milk Extracellular Vesicles as Revealed by Metabolomic Profile. Nutrients 12:10, pages 2908.
Crossref
Eliot A. Brinton, Joseph Triscari, Philippe Brudi, Erluo Chen, Amy O. Johnson-Levonas, Christine McCrary Sisk, Rae Ann Ruck, Alexandra A. MacLean, Darbie Maccubbin & Yale B. Mitchel. (2016) Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes. Lipids in Health and Disease 15:1.
Crossref
Jia Pu, Robert Romanelli, Beinan Zhao, Kristen M.J. Azar, Katherine G. Hastings, Vani Nimbal, Stephen P. Fortmann & Latha P. Palaniappan. (2016) Dyslipidemia in Special Ethnic Populations. Endocrinology and Metabolism Clinics of North America 45:1, pages 205-216.
Crossref
Petra El KhouryElisa WaldmannThierry HubyJulie GallPhilippe CouvertJean-Marc LacorteJohn ChapmanEric FrisdalPhilippe LesnikKlaus G. ParhoferWilfried Le GoffMaryse Guerin. (2016) Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport. Arteriosclerosis, Thrombosis, and Vascular Biology 36:2, pages 285-294.
Crossref
Jia Pu, Robert Romanelli, Beinan Zhao, Kristen M.J. Azar, Katherine G. Hastings, Vani Nimbal, Stephen P. Fortmann & Latha P. Palaniappan. (2015) Dyslipidemia in Special Ethnic Populations. Cardiology Clinics 33:2, pages 325-333.
Crossref
Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, Carl E. Orringer, Harold E. Bays, Peter H. Jones, James M. McKenney, Scott M. Grundy, Edward A. Gill, Robert A. Wild, Don P. Wilson & W. Virgil Brown. (2015) National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report. Journal of Clinical Lipidology 9:2, pages 129-169.
Crossref
A. RamirezP. P. Hu. (2015) Low High-Density Lipoprotein and Risk of Myocardial Infarction. Clinical Medicine Insights: Cardiology 9, pages CMC.S26624.
Crossref